Fc Receptor–Mediated Inhibitory Effect of Immunoglobulin Therapy on Autoimmune Giant Cell Myocarditis
Authors:
- 14 September 2001
- journal article
- other
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 89 (6) , 540-546
Abstract
Abstract— In the present study, the mechanisms and importance of the Fc portion of immunoglobulin in experimental giant cell myocarditis were examined. Giant cell myocarditis was induced in rats by immunization of porcine cardiac myosin. Human intact immunoglobulin (1 g · kg −1 · d −1 ) or F(ab′) 2 fragments of human immunoglobulin (1 g · kg −1 · d −1 ) were administered intraperitoneally daily on days 1 to 21. Intact immunoglobulin administration significantly ameliorated myocarditis, but F(ab′) 2 fragments did not. The ribonuclease protection assay revealed that therapy with intact immunoglobulin, but not F(ab′) 2 fragments, suppressed the mRNA expressions of inflammatory and proinflammatory cytokines. Immunohistochemical analysis showed that therapy with intact immunoglobulin, but not F(ab′) 2 fragments, suppressed dendritic cell (DC) expression during both the early and the subsequent fulminant phases. Moreover, the early treatment of intact immunoglobulin until the 11th day or 14th day, when the expression of DCs was completely suppressed, ameliorated myocarditis. However, the late treatment of intact immunoglobulin beginning on day 15, when the expression of DCs had already been completed, failed to ameliorate the condition. An in vitro study showed that intact immunoglobulin, but not F(ab′) 2 fragments, suppressed the lipopolysaccharide-induced interleukin-1β production associated with the downregulation of CD32 antigen (Fcγ receptor II) expression. Thus, intact immunoglobulin therapy markedly suppressed myocarditis as a result of Fc receptor–mediated anti-inflammatory action, and the suppression of the disease was associated with the suppression of DCs, ie, the suppression of the initial antigen-priming process in experimental giant cell myocarditis.Keywords
This publication has 18 references indexed in Scilit:
- Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc ReceptorScience, 2001
- Immunoglobulin treatment ameliorates murine myocarditis associated with reduction of neurohumoral activity and improvement of extracellular matrix changeJACC, 2000
- Strain Difference in Rats With Experimental Giant Cell MyocarditisJapanese Circulation Journal, 2000
- Intravenous immune globulin in the therapy of peripartum cardiomyopathyJACC, 1999
- Role of dendritic cells in the induction and maintenance of autoimmune diseasesImmunological Reviews, 1999
- Idiopathic Giant-Cell Myocarditis — Natural History and TreatmentNew England Journal of Medicine, 1997
- Clinical significance of IgG Fc receptors and FcγR-directed immunotherapiesImmunology Today, 1997
- An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.Proceedings of the National Academy of Sciences, 1996
- The MRC OX-62 antigen: a useful marker in the purification of rat veiled cells with the biochemical properties of an integrin.Journal of Experimental Medicine, 1992
- An immunosuppressant compound, FK-506, prevents the progression of autoimmune myocarditis in ratsClinical Immunology and Immunopathology, 1992